2026-04-14T03:43:46Zhttps://recercat.cat/oai/request

oai:recercat.cat:2445/1244862025-12-05T12:33:11Zcom_2072_1057col_2072_478916col_2072_478917

Romiplostim therapy as a second‐line treatment before splenectomy for refractory immune thrombocytopenia in a cirrhotic patient with iatrogenic Cushing syndrome secondary to corticosteroids Casanovas Taltavull, Teresa Peña Cala, Maria Carmen Síndrome de Cushing Administració de medicaments Cushing's syndrome Administration of drugs Key Clinical Message: Our case report discusses the usefulness of administering romiplostim as a second-line treatment before splenectomy in a cirrhotic patient with immune thrombocytopenia who developed corticosteroid-induced Cushing's syndrome. Corticosteroids were tapered and consequently withdrawn. The patient made a full recovery postsplenectomy. 2018-09-12T12:28:05Z 2018-09-12T12:28:05Z 2017-02-01 2018-07-24T12:11:16Z info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion https://hdl.handle.net/2445/124486 28174643 eng Reproducció del document publicat a: https://doi.org/10.1002/ccr3.667 Clinical Case Reports, 2017, vol. 5, num. 2, p. 159-163 https://doi.org/10.1002/ccr3.667 cc by (c) Casanovas Taltavull, Teresa; Peña Cala, Maria Carmen, 2017 http://creativecommons.org/licenses/by/3.0/es/ info:eu-repo/semantics/openAccess 5 p. application/pdf Wiley Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))